Fundz

Sarepta Therapeutics, Inc. reported raising $400 Million in an initial SEC Form D filing, from an offering of $400 Million

PUBLIC · SRPTFeb 28, 2020

Amount Raised

$400 Million

$400 Million sold, per SEC Form D (first sale Feb 28, 2020)

Round Type

Venture

CambridgeBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

Sarepta Therapeutics raised $400 Million in a funding round, dated February 28, 2020. Sarepta Therapeutics is based in Cambridge, Massachusetts, United States.

How much did Sarepta Therapeutics raise?
Sarepta Therapeutics raised $400 Million in a funding round on February 28, 2020.
What does Sarepta Therapeutics do?
Sarepta Therapeutics, Inc. is the leader in precision genetic medicine for rare diseases, with a focus on Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs).
Where is Sarepta Therapeutics based and how big is it?
Sarepta Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 1,461 employees.
Who are the decision-makers at Sarepta Therapeutics?
Fundz holds 4 contacts at Sarepta Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Sarepta Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Crispr Therapeutics raised $1M (Seed) on April 9, 2020.
  • CytoDyn raised $882K (Seed) on March 30, 2020.
  • Olema Pharmaceuticals, Inc. raised $30M on March 27, 2020.
  • Design Therapeutics, Inc. raised $46M on March 20, 2020.
  • Verastem Oncology raised $100M on March 6, 2020.
  • Phio Pharmaceuticals raised $1.9M on February 24, 2020.

Who to call at Sarepta Therapeutics, and when

A new round usually means Sarepta Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sarepta Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sarepta Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sarepta Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sarepta Therapeutics

Location

215 First Street

Cambridge, Massachusetts, United States

About

Sarepta Therapeutics, Inc. is the leader in precision genetic medicine for rare diseases, with a focus on Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs). The company is on a mission to engineer life-changing therapies for patients and has a multi-platform Precision Genetic Medicine Engine driving its vast pipeline.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sarepta Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contacts25 people are listed at Sarepta Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Sarepta Therapeutics's next move

See what Strategic adds

Sarepta Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.